Poor Evidence Underpins Treatments for Hepatorenal Syndrome Poor Evidence Underpins Treatments for Hepatorenal Syndrome

Because almost all studies of treatments for hepatorenal syndrome (HRS) are flawed, one cannot be recommended over another, a systematic review and meta-analysis concludes.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Nephrology News Source Type: news